HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Katayama Selected Research

JTP 2942

5/2001Effect of long-term administration of JTP-2942, a novel thyrotropin-releasing hormone analogue, on neurological outcome, local cerebral blood flow and glucose utilization in a rat focal cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Katayama Research Topics

Disease

12Stroke (Strokes)
03/2009 - 01/2000
11Ischemia
05/2014 - 11/2000
7Infarction (Infarctions)
05/2014 - 01/2001
7Tremor (Tremors)
01/2012 - 01/2000
7Parkinson Disease (Parkinson's Disease)
05/2011 - 10/2000
6Dyskinesias (Dyskinesia)
05/2011 - 01/2000
5Hypertension (High Blood Pressure)
03/2009 - 03/2001
4Infections
10/2014 - 02/2000
4Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2012 - 09/2000
4Movement Disorders (Movement Disorder)
01/2006 - 12/2001
4Edema (Dropsy)
01/2003 - 10/2001
4Pain (Aches)
01/2003 - 01/2000
4Hemorrhage
10/2001 - 08/2000
3Neoplasms (Cancer)
09/2017 - 02/2001
3Ischemic Stroke
05/2014 - 03/2007
3Persistent Vegetative State (Vegetative State)
01/2005 - 01/2002
3Protein C Deficiency
08/2001 - 01/2000
3Cerebral Infarction
08/2001 - 01/2000
2Bipolar Disorder (Manic Depressive Psychosis)
09/2016 - 05/2014
2Graft vs Host Disease (Graft-Versus-Host Disease)
11/2009 - 10/2000
2Brain Contusion
01/2007 - 01/2006
2Brain Edema (Cerebral Edema)
01/2006 - 01/2003
2Necrosis
03/2005 - 01/2000
2Body Weight (Weight, Body)
08/2003 - 05/2002
2Essential Tremor (Essential Tremors)
01/2003 - 12/2001
2Wounds and Injuries (Trauma)
01/2003 - 11/2000
2Hypothermia
01/2003 - 01/2003
2Brain Ischemia (Cerebral Ischemia)
01/2003 - 05/2001
2Disease Progression
06/2002 - 01/2000
2Hemolysis
12/2001 - 08/2000
2Hypokinesia (Bradykinesia)
12/2001 - 10/2000
2Essential Hypertension
09/2001 - 08/2000
2Alzheimer Disease (Alzheimer's Disease)
01/2001 - 02/2000
2Hematologic Neoplasms (Hematological Malignancy)
11/2000 - 10/2000
2Arterial Occlusive Diseases (Arterial Occlusive Disease)
04/2000 - 01/2000
2Intractable Pain
04/2000 - 01/2000
1Brain Neoplasms (Brain Tumor)
09/2017
1Glioma (Gliomas)
09/2017
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
09/2014
1Fever (Fevers)
09/2014
1Mood Disorders (Mood Disorder)
05/2014
1Hypesthesia (Numbness)
06/2013
1Erythromelalgia (Erythermalgia)
06/2013
1Foodborne Diseases
06/2013
1Residual Neoplasm
06/2012
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2012
1Patent Ductus Arteriosus
01/2011
1Philadelphia Chromosome
05/2010

Drug/Important Bio-Agent (IBA)

4Tissue Plasminogen Activator (Alteplase)FDA Link
03/2007 - 01/2000
4Glucose (Dextrose)FDA LinkGeneric
01/2003 - 02/2000
3Indicators and Reagents (Reagents)IBA
09/2017 - 02/2001
3Neuroprotective AgentsIBA
01/2003 - 10/2001
3Proteins (Proteins, Gene)FDA Link
06/2002 - 01/2000
3Protein CIBA
08/2001 - 01/2000
3Immunoglobulin G (IgG)IBA
10/2000 - 08/2000
2Lamotrigine (Lamictal)FDA LinkGeneric
09/2016 - 05/2014
2Biomarkers (Surrogate Marker)IBA
03/2015 - 09/2001
2Dopamine (Intropin)FDA LinkGeneric
05/2011 - 07/2001
2Pharmaceutical PreparationsIBA
05/2011 - 05/2001
2SaltsIBA
12/2010 - 09/2010
2GABA-A Receptors (GABA(A) Receptor)IBA
04/2008 - 02/2000
2Free Radical ScavengersIBA
03/2007 - 01/2003
2EdaravoneIBA
03/2007 - 01/2003
2Tacrolimus (Prograf)FDA LinkGeneric
01/2003 - 10/2001
2Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2003 - 10/2001
2SuspensionsIBA
01/2003 - 06/2001
2EnzymesIBA
06/2002 - 02/2001
2Dihydroxyphenylalanine (Dopa)IBA
12/2001 - 10/2000
2CalciumIBA
10/2001 - 09/2000
2Immunosuppressive Agents (Immunosuppressants)IBA
10/2001 - 08/2000
2Thyrotropin-Releasing Hormone (Protirelin)FDA Link
09/2001 - 05/2001
2Eosine Yellowish-(YS) (Eosin)IBA
05/2001 - 01/2001
2alpha-SynucleinIBA
01/2001 - 07/2000
1AcidsIBA
09/2017
1protoporphyrin IXIBA
09/2017
1Antineoplastic Agents (Antineoplastics)IBA
03/2015
1CathepsinsIBA
03/2015
1VancomycinFDA LinkGeneric
10/2014
1Valproic Acid (Depakote)FDA LinkGeneric
05/2014
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2013
1MycotoxinsIBA
06/2013
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
03/2013
1Peptides (Polypeptides)IBA
06/2012
1Zonisamide (Zonegran)FDA LinkGeneric
01/2012
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
05/2011
1RacloprideIBA
05/2011
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
05/2011
1Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric
01/2011
1Indomethacin (Indometacin)FDA LinkGeneric
01/2011
1Hydrocortisone (Cortisol)FDA LinkGeneric
12/2010

Therapy/Procedure

16Therapeutics
05/2014 - 01/2000
12Deep Brain Stimulation
01/2006 - 01/2000
3Electrodes (Electrode)
01/2003 - 11/2000
3Blood Transfusion (Blood Transfusions)
05/2002 - 08/2000
2Transplantation
09/2014 - 05/2014
2Punctures
09/2010 - 01/2005
2Catheters
01/2007 - 07/2004
2Suture Techniques
01/2003 - 01/2003
2Spinal Cord Stimulation
01/2001 - 01/2001
1Organ Transplantation
09/2014